Shares of Abbott and other COVID-19 test makers plunge as disease declines
1 June medical giant Abbott Laboratories (NYSE: ABT) reported a sharp drop in demand for coronavirus diagnostics. The company downgraded its forecast for adjusted net income per share from 5 up to 4.3-4.5 $. Abbott shares fell by 9,3%.